Unknown

Dataset Information

0

SFRP1 exerts effects on gastric cancer cells through GSK3?/Rac1?mediated restraint of TGF?/Smad3 signaling.


ABSTRACT: Secreted frizzled?related protein 1 (sFRP1) is an inhibitor of canonical Wnt signaling; however, previous studies have determined a tumor?promoting function of sFRP1 in a number of different cancer types. A previous study demonstrated that sFRP1 overexpression was associated with an aggressive phenotype and the activation of transforming growth factor ? (TGF?) signaling. sFRP1 overexpression and sFRP1 knockdown cell models were established. Immunoblotting was conducted to examine the protein levels of the associated molecules. Immunofluorescence staining followed by confocal microscopy was performed to visualize the cytoskeleton alterations and subcellular localization of key proteins. sFRP1 overexpression restored glycogen synthase kinase 3? (GSK3?) activity, which activated Rac family small GTPase 1 (Rac1). GSK3? and Rac1 mediated the effect of sFRP1 on the positive regulation of cell growth and migration/invasion. Inhibition of GSK3? or Rac1 abolished the regulation of sFRP1 on TGF?/SMAD family member 3 (Smad3) signaling and the aggressive phenotype; however, GSK3? or Rac1 overexpression increased cell migration/invasion and restrained Smad3 activity by preventing its nuclear translocation and limiting its transcriptional activity. The present study demonstrated a tumor?promoting function of sFRP1?overexpression by selectively activating TGF? signaling in gastric cancer cells. GSK3? and Rac1 serve an important function in mediating the sFRP1?induced malignant alterations and signaling changes.

SUBMITTER: Peng JX 

PROVIDER: S-EPMC6278527 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

sFRP1 exerts effects on gastric cancer cells through GSK3β/Rac1‑mediated restraint of TGFβ/Smad3 signaling.

Peng Ji-Xiang JX   Liang Shun-Yu SY   Li Li L  

Oncology reports 20181031 1


Secreted frizzled‑related protein 1 (sFRP1) is an inhibitor of canonical Wnt signaling; however, previous studies have determined a tumor‑promoting function of sFRP1 in a number of different cancer types. A previous study demonstrated that sFRP1 overexpression was associated with an aggressive phenotype and the activation of transforming growth factor β (TGFβ) signaling. sFRP1 overexpression and sFRP1 knockdown cell models were established. Immunoblotting was conducted to examine the protein lev  ...[more]

Similar Datasets

| S-EPMC5261001 | biostudies-literature
| S-EPMC3991551 | biostudies-literature
| S-EPMC8650352 | biostudies-literature
| S-EPMC7957200 | biostudies-literature
| S-EPMC7843612 | biostudies-literature
| S-EPMC7302877 | biostudies-literature
| S-EPMC8750349 | biostudies-literature
| S-EPMC8091105 | biostudies-literature
| S-EPMC5417360 | biostudies-literature
| S-EPMC4557666 | biostudies-literature